Rat carotid artery responses to α-adrenergic receptor agonists and 5-HT after ovariectomy and hormone replacement

Headache

Volumn 47, Issue 2, 2007, Pages 236-246

  Mehrotra, Suneet ^a   Gupta, Saurabh ^a   Villalón, Carlos M ^b   Boomsma, Frans ^a   Saxena, Pramod R ^a   MaassenVanDenBrink, Antoinette ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

adrenergic receptor; 17 estradiol; 5 hydroxytryptamine; Carotid artery; Migraine; Progesterone

Indexed keywords

ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; COCAINE; CORTICOSTERONE; ESTRADIOL; GLUTATHIONE TRANSFERASE; HEPARIN; N [5 (4,5 DIHYDRO 1H IMIDAZOL 2 YL) 5,6,7,8 TETRAHYDRO 2 HYDROXY 1 NAPHTHYL]METHANESULFONAMIDE; NORADRENALIN; PLACEBO; PRAZOSIN; PROGESTERONE; RAUWOLSCINE; SEROTONIN; SEX HORMONE;

ACCLIMATIZATION; ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD SAMPLING; CAROTID ARTERY; CONTROLLED STUDY; DRUG PELLET; DRUG POTENCY; DRUG RESPONSE; FEMALE; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; MIGRAINE; MYOGRAPHY; NONHUMAN; NORADRENALIN BLOOD LEVEL; OVARIECTOMY; PRIORITY JOURNAL; RAT; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CAROTID ARTERIES; EPINEPHRINE; ESTRADIOL; FEMALE; IMIDAZOLES; MIGRAINE DISORDERS; NOREPINEPHRINE; OVARIECTOMY; PHENYLEPHRINE; POTASSIUM CHLORIDE; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; SEROTONIN; SEROTONIN AGENTS; TETRAHYDRONAPHTHALENES; VASOCONSTRICTION;

EID: 33846960191     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00530.x     Document Type: Article

References (64)

1. Stewart WF, Linet MS, Celentano DD, Van Natta M, Ziegler D. Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol. 1991;134:1111-1120.
2. MacGregor EA. Oestrogen and attacks of migraine with and without aura. Lancet Neurol. 2004;3:354-361.
3. Silberstein SD. The role of sex hormones in headache. Neurology. 1992;42:37-42.
4. MacGregor EA, Igarashi H, Wilkinson M. Headaches and hormones: Subjective versus objective assessment. Headache Q. 1997;8:126-136.
5. Couturier EG, Bomhof MA, Neven AK, van Duijn NP. Menstrual migraine in a representative Dutch population sample: Prevalence, disability and treatment. Cephalalgia. 2003;23:302-308.
6. Ashkenazi A, Silberstein SD. Hormone-related headache: Pathophysiology and treatment. CNS Drugs. 2006;20:125-141.
7. Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology. 1972;22:355-365.
8. Somerville BW. Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology. 1975;25:239-244.
9. Martin VT, Wernke S, Mandell K, et al. Defining the relationship between ovarian hormones and migraine headache. Headache. 2005;45:1190-1201.
10. MacGregor EA. Female sex hormones and migraine. Rev Neurol (Paris). 2005;161:677-678.
11. Stein G, Morton J, Marsh A, et al. Headaches after childbirth. Acta Neurol Scand. 1984;69:74-79.
12. Dennerstein L, Morse C, Burrows G, Oats J, Brown J, Smith M. Menstrual migraine: A double-blind trial of percutaneous estradiol. Gynecol Endocrinol. 1988;2:113-120.
13. De Lignieres B, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG. Prevention of menstrual migraine by percutaneous oestradiol. Br Med J. 1986;293:1540.
14. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med. 2002;346:257-270.
15. Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: A comparative review of pharmacology, pharmacokinetics and efficacy. Drugs. 2000;60:1259-1287.
16. Villalón CM, Centurión D, Valdivia LF, De Vries P, Saxena PR. Migraine: Pathophysiology, pharmacology, treatment and future trends. Curr Vasc Pharmacol. 2003;1:71-84.
17. 1B/1D receptor agonists in the acute treatment of migraine. In: Olesen J, Goadsby PJ, Ramadan N, Tfelt-Hansen P, Welch KMA, eds. The Headaches, Philadelphia: Lippincott Williams & Wilkins; 2005;469-503.
18. Blau JN. Migraine: A vasomotor instability of the meningeal circulation. Lancet. 1978;2:1136-1139.
19. Jensen K. Extracranial blood flow, pain and tenderness in migraine. Clinical and experimental studies. Acta Neurol Scand Suppl. 1993;147:1-27.
20. Johnston BM, Saxena PR. The effect of ergotamine on tissue blood flow and the arteriovenous shunting of radioactive microspheres in the head. Br J Pharmacol. 1978;63:541-549.
21. Spierings EL, Saxena PR. Pharmacology of arteriovenous anastomoses. Adv Neurol. 1982;33:291-294.
22. Saxena PR, Koedam NA, Heiligers J, Hof RP. Ergotamine-induced constriction of cranial arteriovenous anastomoses in dogs pretreated with phentolamine and pizotifen. Cephalalgia. 1983;3:71-81.
23. Den Boer MO, Somers JA, Saxena PR. Comparative effects of the antimigraine drugs sumatriptan and ergotamine on the distribution of cardiac output in anaesthetized pigs. Cephalalgia. 1992;12:206-213.
24. Willems EW, Valdivia LF, Villalón CM, Saxena PR. Possible role of α-adrenoceptor subtypes in acute migraine therapy. Cephalalgia. 2003;23:245-257.
25. Choppin A, O'Connor SE. Influence of vascular tone on vasoconstrictor responses to the 5-HT 1-like receptor agonist sumatriptan in anaesthetised rabbits. Eur J Pharmacol. 1996;304:87-92.
26. Watts SW, Yeum CH, Campbell G, Webb RC. Serotonin stimulates protein tyrosyl phosphorylation and vascular contraction via tyrosine kinase. J Vasc Res. 1996;33:288-298.
27. 1A- adrenoceptor-mediated vasoconstriction in vitro. J Auton Pharmacol. 2000;20:139-145.
28. 1D receptors in sumatriptan mediated vasocontractile response in rabbit common carotid artery. Br J Pharmacol. 2002;136:177-182.
29. 1-adrenoceptor subtypes in dog mesenteric and carotid arteries and rabbit carotid arteries. Br J Pharmacol. 1991;102:210-214.
30. Andersen HL, Weis JU, Fjalland B, Korsgaard N. Effect of acute and long-term treatment with 17β-estradiol on the vasomotor responses in the rat aorta. Br J Pharmacol. 1999;126:159-168.
31. Ma L, Yu Z, Xiao S, Thadani U, Robinson CP, Patterson E. Supersensitivity to serotonin- and histamine-induced arterial contraction following ovariectomy. Eur J Pharmacol. 1998;359:191-200.
32. 2-adrenoceptor reactivity. Endothelium. 1998;6:133-141.
33. Gisclard V, Flavahan NA, Vanhoutte PM. α-Adrenergic responses of blood vessels of rabbits after ovariectomy and administration of 17β-estradiol. J Pharmacol Exp Ther. 1987;240:466-470.
34. A receptors in the parabrachial nucleus. Brain Res. 2003;973:161-170.
35. Tollan A, Oian P, Kjeldsen SE, Eide I, Maltau JM. Progesterone reduces sympathetic tone without changing blood pressure or fluid balance in men. Gynecol Obstet Invest. 1993;36:234-238.
36. Peroutka SJ. Migraine: A chronic sympathetic nervous system disorder. Headache. 2004;44:53-64.
37. Gupta S, Villalón CM, Mehrotra S, et al. Female sex hormones and rat dural vasodilatation to CGRP, periarterial electrical stimulation and capsaicin. Headache. 2006; In press.
38. Van der Hoorn FA, Boomsma F, Man in 't Veld AJ, Schalekamp MA. Determination of catecholamines in human plasma by high-performance liquid chromatography: Comparison between a new method with fluorescence detection and an established method with electrochemical detection. J Chromatogr. 1989;487:17-28.
39. Nyborg NC, Baandrup U, Mikkelsen EO, Mulvany MJ. Active, passive and myogenic characteristics of isolated rat intramural coronary resistance arteries. Pflugers Arch. 1987;410:664-670.
40. MaassenVanDenBrink A, Bax WA, Ferrari MD, Zijlstra FJ, Bos E, Saxena PR. Augmented contraction of the human isolated coronary artery by sumatriptan: Apossible role for endogenous thromboxane. Br J Pharmacol. 1996;119:855-862.
41. MaassenVanDenBrink A, Reekers M, Bax WA, Ferrari MD, Saxena PR. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation. 1998;98:25-30.
42. Veille JC, Li P, Eisenach JC, Massmann AG, Figueroa JP. Effects of estrogen on nitric oxide biosynthesis and vasorelaxant activity in sheep uterine and renal arteries in vitro. Am J Obstet Gynecol. 1996;174:1043-1049.
43. Dai Z, Zhu HQ, Jiang DJ, Jiang JL, Deng HW, Li YJ. 17β-estradiol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. Int J Cardiol. 2004;96:223-227.
44. Dubey RK, Jackson EK. Estrogen-induced cardiorenal protection: Potential cellular, biochemical, and molecular mechanism. Am J Physiol (Renal Physiol). 2001;280:F365-F388.
45. 2+ entry mechanisms of coronary vasoconstriction. Arterioscler Thromb Vasc Biol. 1999;19:1034-1040.
46. 2+]i during inhibition of coronary smooth muscle contraction by 17β-estradiol, progesterone, and testosterone. J Pharmacol Exp Ther. 1999;291:44-52.
47. Jiang C, Sarrel PM, Poole-Wilson PA, Collins P. Acute effect of 17β-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol. 1992;263:H271-H275.
48. Zhang M, Benishin CG, Pang PKT. Rapid inhibition of the contraction of rat tail artery by progesterone is mediated by inhibition of calcium currents. J Pharm Pharmacol. 2002;54:1667-1674.
49. + channels in human coronary artery smooth muscle cells. Cardiovasc Res. 2002;53:650-661.
50. Tep-Areenan P, Kendall DA, Randall MD. Mechanism of vasorelaxation to 17β-oestradiol in rat arteries. Eur J Pharmacol. 2003;476:139-149.
51. Vedernikov YP, Liao QP, Jain V, Saade GR, Chwalisz K, Garfield RE. Effect of chronic treatment with 17β-estradiol and progesterone on endothelium-dependent and endothelium-independent relaxation in isolated aortic rings from ovariectomized rats. Am J Obstet Gynecol. 1997;176:603-608.
52. Miyagawa K, Rosch J, Stanczyk F, Hermsmeyer K. Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm. Nat Med. 1997;3:324-327.
53. Moura MJ, Marcondes FK. Influence of estradiol and progesterone on the sensitivity of rat thoracic aorta to noradrenaline. Life Sci. 2001;68:881-888.
54. Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol. 1991;261:R1022-R1027.
55. Vu Hai MT, Warembourg M, Milgrom E. Hormonal control of progesterone receptors. Ann NY Acad Sci. 1977;286:199-209.
56. Horwitz KB, Koseki Y, McGuire WL. Estrogen control of progesterone receptor in human breast cancer: Role of estradiol and antiestrogen. Endocrinology. 1978;103:1742-1751.
57. Dogterom J, De Jong W. Diminished pressor response to noradrenaline of the perfused tail artery of pregnant rats. Eur J Pharmacol. 1974;25:267-269.
58. Horth CE, Wainscott G, Neylan C, Wilkinson MI. Proceedings: Progesterone, oestradiol and aldosterone levels in plasma during the menstrual cycle of women suffering from migraine. J Endocrinol. 1975;65:24P-25P.
59. Mosek A, Novak V, Opfer-Gehrking TL, Swanson JW, Low PA. Autonomic dysfunction in migraineurs. Headache. 1999;39:108-117.
60. Ostertag D, Strittmatter M, Schimrigk K. Autonome Regulationsstorung bei Migrane und Spannungskopfschmerz. Pilotstudie. Schmerz. 1998;12:25-29.
61. Khalil RA. Sex hormones as potential modulators of vascular function in hypertension. Hypertension. 2005;46:249-254.
62. Zhang Y, Davidge ST. Effect of estrogen replacement on vasoconstrictor responses in rat mesenteric arteries. Hypertension. 1999;34:1117-1122.
63. 1-adrenoceptor in rat submandibular gland. Auton Neurosci. 2003;103:13-18.
64. 2-adrenoceptor agonist (BHT-933) in man. J Cardiovasc Pharmacol. 1982;4:527-530.